Opinion: Former Surgeon General Jerome Adams: Prioritize new antivirals for Covid
"This is an issue of health equity," writes former Surgeon General Jerome Adams.
The U.S. Covid-19 Public Health Emergency declaration may have ended, but the virus remains. Now is the moment to leverage the successes and challenges of fostering innovative Covid therapeutics to prepare for the future waves that we inevitably face from new variants.
On June 13, the House Energy and Commerce Committee’s Subcommittee on Health convened to discuss solutions to ensure preparedness for the next generation of public threats and hazards, including infectious diseases such as Covid-19. This was a critical discussion, particularly because seniors and immunocompromised patients remain susceptible to harm from Covid-19 and continue to have limited treatment options.
What's Your Reaction?
